CD19-negative relapse in adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia following treatment with blinatumomab-a post hoc analysis.

Authors :: Horst HA
Zugmaier G
Martinelli G
Mergen N
Velasco K
Zaman F
Kantarjian H
Source :: American journal of hematology [Am J Hematol] 2023 Aug; Vol. 98 (8), pp. E222-E225. Date of Electronic Publication: 2023 Jun 22.
Publication Year :: 2023

Subjects :: Humans
Adult
Recurrence
Antigens, CD19 therapeutic use
Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy
Antibodies, Bispecific adverse effects
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma drug therapy
Antineoplastic Agents adverse effects

Full Text Access

Tools